Skip to search formSkip to main contentSkip to account menu

SK&F 10047

Known as: 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-propenyl)-, SKF 10047, SKF-10047 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Antipsychotic AgentsPhenazocine

Narrower (1)

SK&F 10047, monolactate
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
[Partial purification of endogenous inhibitors of (+)-[3H] SKF 10047 binding with sigma-opioid receptors of the liver].
Porcine liver extract inhibits (+)-[3H]SKF 10047 binding to rat liver membranes. The inhibitors of (+)-[3H]SKF 10047 binding were… 
1986
1986
Specific binding of a ligand of sigma-opioid receptors - N-allylnormetazocine (SKF 10047) - with liver membranes
A ligand of the sigma-opioid receptors - N-allylnormetazocine (SKF 10047) -binds specifically and reversible with rat liver… 
1985
1985
[Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
: A sigma-opioid receptor ligand, N-allylnormetazocine (SKF 10047), binds specifically and reversibly to rat liver membranes. The… 
1985
1985
[Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
A sigma-opioid receptor ligand, N-allylnormetazocine (SKF 10047), binds specifically and reversibly to rat liver membranes. The… 
1984
1984
Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
The effects of some opiates on the horizontal and vertical components of locomotor activity in mice were measured in actometers… 
1983
1983
Partial characterization of the specific binding of 3H-N-allylnormetazocine (SKF 10047) to rat brain membranes
1981
1981
Pharmacologic effects of N-allylnormetazocine (SKF-10047).
  • I. Et
  • 1981
  • Corpus ID: 80915646